Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone
- PMID: 7508329
- DOI: 10.1192/bjp.163.6.833
Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone
Erratum in
- Br J Psychiatry 1994 Feb;164:270
Similar articles
-
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.Psychopharmacology (Berl). 1995 Jan;117(1):55-61. doi: 10.1007/BF02245098. Psychopharmacology (Berl). 1995. PMID: 7536945 Clinical Trial.
-
Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.Biol Psychiatry. 1992 Aug 1;32(3):293-5. doi: 10.1016/0006-3223(92)90111-c. Biol Psychiatry. 1992. PMID: 1358229 No abstract available.
-
Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.Psychiatry Res. 1999 Nov 8;92(1):33-44. doi: 10.1016/s0925-4927(99)00032-3. Psychiatry Res. 1999. PMID: 10688158 Clinical Trial.
-
Risperidone: clinical issues in treatment.J Psychosoc Nurs Ment Health Serv. 1994 May;32(5):47-9. doi: 10.3928/0279-3695-19940501-18. J Psychosoc Nurs Ment Health Serv. 1994. PMID: 7519677 Review. No abstract available.
-
Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S46-52. Can J Psychiatry. 1994. PMID: 7533051 Review.
Cited by
-
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.Psychopharmacology (Berl). 1995 Jan;117(1):55-61. doi: 10.1007/BF02245098. Psychopharmacology (Berl). 1995. PMID: 7536945 Clinical Trial.
-
Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.Drugs. 1994 Aug;48(2):253-73. doi: 10.2165/00003495-199448020-00009. Drugs. 1994. PMID: 7527327 Review.
-
Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies.CNS Drugs. 2001;15(9):671-8. doi: 10.2165/00023210-200115090-00001. CNS Drugs. 2001. PMID: 11580306 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical